Results 191 to 200 of about 56,782 (308)

Hypoalbuminemia as a prognostic marker for survival in biliary tract cancer: associations with tumor type, treatment and sex. [PDF]

J Cancer Res Clin Oncol
Abdulrazzak M, Björkhem-Bergman L, Villard C, Gerling M, Gustavell T, Jansson H.   +5 more
europepmc   +1 more source

Point-of-Care Testing and Biomarkers in Biliary Diseases: Current Evidence and Future Directions. [PDF]

J Clin Med
Jung JH, Lee KJ, Park SW, Koh DH, Lee J.
europepmc   +1 more source

Re-evaluation of the Treatment of Pancreatitis Associated with Biliary Tract Disease

, 1964
Frank Glenn, Charles F. Frey
openalex   +2 more sources

Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy

Medicine Bulletin, EarlyView.
ABSTRACT Recently, immune checkpoint inhibitors (ICIs), particularly PD‐1/PD‐L1 and CTLA‐4 inhibitors, have revolutionized cancer treatment, significantly improving survival rates for various malignancies. However, ICI therapies targeting single checkpoints on T cells still face numerous challenges, such as low response rates and post‐treatment ...
Yangyang Li, Zizhen Kang, Yanyun Du
wiley   +1 more source

Biliary microbiota in disease-free, obstructive and post-drainage biliary tracts. [PDF]

Front Cell Infect Microbiol
Zhang G, Zeng L, Chen B, Dai H, Tang K, Huang R, Xiang X, Yang J, Yang J, Song X, Ma Y, Lin R, Huang Y.   +12 more
europepmc   +1 more source

Incidence and Mortality Risks of Gastrointestinal Cancers During Working‐Age Period: Trends and Disparities in 204 Countries and Territories (1990–2021)

Med Research, EarlyView.
This comprehensive analysis of gastrointestinal (GI) cancer risk reveals that globally, one in 46 people will develop and one in 73 will die from GI cancers during working age (15–64 years), with 2021 incidence and mortality risks of 2.19% and 1.37%, respectively. Key findings demonstrate striking gender disparities, with males facing nearly double the
Yiming Song, Zhongge Ji, Xunbing Zhang, Qian Liang, Zeyu Li, Xiaojie Huang, Jinnan Chen, Yujie Zhou, Xinyuan Wang, Zhao Li, Liuyi Yang, Yixin Qian, Xiaolu Lin, Qingwei Zhang, Xiaobo Li   +14 more
wiley   +1 more source

Biliary ascariasis without cholangitis: an unusual presentation in an endemic region. [PDF]

Oxf Med Case Reports
Nabil, Zohaib MA, Zubair M, Shafique U, Iqbal J, Hussain A.   +5 more
europepmc   +1 more source

Bile Acid Binding Resins Improve Glucagon Receptor Agonist‐Mediated Weight Loss in Diet‐Induced Obese Mice

Obesity, EarlyView.
ABSTRACT Objective Glucagon‐receptor (GCGR) agonism reguglates bile acid (BA) metabolism and promotes weight loss in diet‐induced obese (DIO) mice. Thus, we hypothesized that BA signaling contributes to GCGR‐stimulated weight loss. Methods To test this hypothesis, we utilized BA‐binding resins (BARs; colesevelam [Colsv] and cholestyramine [Cstyr]) to ...
Teayoun Kim, Mackenzie J. Pearson, Huixian Hong, Shelly Nason, Khadija Seck, Jessica Antipenko, Natalie Presedo, Richard DiMarchi, William C. Roell, Kirk Habegger   +9 more
wiley   +1 more source

A Preliminary Exploratory Study on the Application of Gd-EOB-DTPA-Enhanced MRI for Assessing Gallbladder Ejection Fraction in Cholecystolithiasis Patients. [PDF]

Can J Gastroenterol Hepatol
Zhang R, Chen B, Li X, Zheng X, Liu Y, Zhang R, Zeng Q, Tian H, He Q, Wu S, Gao Y, Li Z, Lyu H, Liu J.   +13 more
europepmc   +1 more source